|
|
Article: P&G, Curis to develop hair-growth treatments.(P and G Pharmaceuticals)
- Article from:
- Chain Drug Review
- Article date:
- March 27, 2006
CopyrightCOPYRIGHT 2006 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK -- The weakness of the hair-growth products category has not deterred Procter & Gamble Co. (P&G) from investing in the market's future.
Sales in the category slid 9.1% to $53.6 million in drug, food and discount outlets (excluding Wal-Mart Stores Inc.) in the year ended January 22, according to Information Resources Inc. Unit volume tumbled 10.1% to 1.93 million.
Nonetheless P&G Pharmaceuticals last year entered into an exclusive agreement with drug company Curis Inc. to evaluate and develop potential treatments for hair-growth regulation utilizing Curis' hedgehog agonist technology.
Under the terms of the agreement, the company has ...